We used the cancer-type specific genes (IDH1, PTEN, TP53, KRAS, AC008575.1, APC) in TOOme (He et al., 2020b) to evaluate the performance of somatic mutations detected in tissue or ctNDA for identifying the tumor tissue origin. This evidence concerns the gene PTEN and neoplasm.